The Good News and Bad News About Where Precision Medicine Stands in 2020
Effective communication with providers and patients can bridge the gap that exists between precision medicine’s benefits and wider patient access...
Genetic Medicine
Clinicians Looking for Guidance on Pharmacogenomic Testing in Psychiatry
With precision medicine gaining momentum as a guiding approach to healthcare practice and treatments, early pharmacogenomic testing in the consumer market is laying some of the foundation for use in psychiatry...
To Demonstrate Precision Medicine Utility, Focus on Pharmacogenetics Studies and Data
Focus on pharmacogenetics studies and data that demonstrate costs savings and improved outcomes...
Precision Medicine Programs Can Attain ROI Sooner Than Some Naysayers Maintain
Focusing on the right factors can accelerate a precision medicine program’s ROI...
Hospitals Hit with Readmission Penalties; Some of Those Not Hit Used Precision Medicine in Strategy
As CMS announces readmission penalties for nearly 2,600 hospitals, some hospitals and health systems are finding precision medicine and big data efforts to be a new strategy for reducing 30-day readmissions...
UCSF Steps Up Biobanking Program Efforts, Naming Its First Chief Biobank Officer
Analysts predict that the global tissue banking market will grow to nearly $3 billion by 2026. Health executives at UCSF have recognized this trend and are executing on plan to attract patients and funding, and ultimately improve outcomes...
Independent and Rural Hospitals Closing at Record Rates, Vulnerable Patients at Risk of Missing Out on Precision Medicine's Potential
Studies by KHN, Navigant, and others report that independent rural hospitals are closing at record rates, leaving patients without critical nearby healthcare services, including precision medicine’s benefits...
Do Multigene Panels Offer Cancer Patients, Payers More Value?
Daryl Pritchard, PhD, discusses the untapped potential of multi-gene panel sequencing and targeted therapies for patients with advanced cancer....
Why the Cleveland Clinic Uses Telegenetics, Chatbots to Address Genetic Cancer Risk
Charis Eng, MD, PhD, explains how the Cleveland Clinic is overcoming workforce challenges in clinical cancer genetics...
The Essential Ingredients for Pushing Precision Medicine Forward
Mary Zutter, MD, to share Vanderbilt’s lessons learned in assembling resources, selecting disease targets, and engaging physicians in precision medicine pursuits...